{"schema_version":"1","generated_at":"2026-11-04T15:14:48.562Z","data_as_of":"2026-11-03","url":"https://www.findmykol.com/kol/noah-kolb","json_url":"https://www.findmykol.com/kol/noah-kolb/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"noah-kolb","name":"Noah Kolb","credential":"MD","title":"Professor, Neurological Sciences","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"University of Vermont","institution_url":"https://www.findmykol.com/institution/university-of-vermont","city":"Burlington","state":"VT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1427217264","orcid":"0000-0003-2651-2349","openalex":"A5081567758"},"summary":"Noah Kolb is Professor, Neurological Sciences at University of Vermont. OpenAlex indexes 61 publications with 2,201 citations (h-index 23); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Noah Kolb, M.D., is Professor, Neurological Sciences at University of Vermont. The public record shows 61 publications with 2,201 citations (h-index 23), centered on Peripheral Neuropathies and Disorders, Cancer Treatment and Pharmacology, Hereditary Neurological Disorders. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2021–2026).","bullets":["Top research focus: Peripheral Neuropathies and Disorders","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 3 companies"],"generated_at":"2026-11-03"},"focus":{"indications":[{"label":"Pain","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Neuralgia","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Multiple Sclerosis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"CIDP / Inflammatory Neuropathy","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1}],"research_topics":["Peripheral Neuropathies and Disorders","Cancer Treatment and Pharmacology","Hereditary Neurological Disorders","Peripheral Nerve Disorders","Cancer survivorship and care"],"drugs_studied":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Vyvgart","generic":"Efgartigimod alfa","trials":0,"payments":15,"publications":0,"mentions":15},{"name":"Vyvgart Hytrulo","generic":"Efgartigimod alfa / hyaluronidase","trials":0,"payments":11,"publications":0,"mentions":11},{"name":"Firdapse","generic":"Amifampridine","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Argenx Us, Inc.","trials":0,"payments":26,"mentions":26},{"name":"Catalyst Pharmaceuticals, Inc.","trials":0,"payments":1,"mentions":1},{"name":"Disarm Therapeutics","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":61,"cited_by_count":2201,"h_index":23,"i10_index":30,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06614322","title":"SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"University of Rochester","source_url":"https://clinicaltrials.gov/study/NCT06614322","trial_url":"https://www.findmykol.com/trial/NCT06614322"},{"nct":"NCT04763356","title":"Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"University of Vermont","source_url":"https://clinicaltrials.gov/study/NCT04763356","trial_url":"https://www.findmykol.com/trial/NCT04763356"},{"nct":"NCT03997981","title":"Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY)","status":"UNKNOWN","role":"Investigator","sponsor":"Disarm Therapeutics","source_url":"https://clinicaltrials.gov/study/NCT03997981","trial_url":"https://www.findmykol.com/trial/NCT03997981"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":2024},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"ARGENX US, INC.","program_year":2024,"amount_usd":16178.24,"payment_count":26,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427217264"},{"payer":"UCB, Inc.","program_year":2024,"amount_usd":1410,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427217264"},{"payer":"CATALYST PHARMACEUTICALS, INC.","program_year":2021,"amount_usd":1750,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1427217264"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1427217264","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":71,"classes_total":5,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":32.3,"drugs":[{"name":"Gabapentin","share_pct":80.9},{"name":"Pregabalin","share_pct":19.1}],"max_beneficiaries":null},{"class":"SNRI","setting":"prescribed","share_pct":17.3,"drugs":[{"name":"Duloxetine Hcl","share_pct":100}],"max_beneficiaries":18}]},{"area":"Metabolism & gastrointestinal","share_pct":10.7,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":10.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":9.7,"classes_total":1,"classes":[{"class":"Antiarrhythmic","setting":"prescribed","share_pct":9.7,"drugs":[{"name":"Mexiletine Hcl","share_pct":65.9},{"name":"Lidocaine","share_pct":34.1}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"mixed","data_year":2024,"office_pct":49.7,"facility_pct":50.3},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2021,"last":2026},"rows_total":6,"shown":3,"withheld":3,"rows":[{"project":"R01CA247517","title":"Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy","fiscal_year":2026,"amount_usd":372282,"organization":"UNIVERSITY OF VERMONT & ST AGRIC COLLEGE","source_url":"https://reporter.nih.gov/quickSearch/R01CA247517"},{"project":"R01CA247517","title":"Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy","fiscal_year":2025,"amount_usd":1393948,"organization":"UNIVERSITY OF VERMONT & ST AGRIC COLLEGE","source_url":"https://reporter.nih.gov/quickSearch/R01CA247517"},{"project":"R01CA247517","title":"Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy","fiscal_year":2024,"amount_usd":1540842,"organization":"UNIVERSITY OF VERMONT & ST AGRIC COLLEGE","source_url":"https://reporter.nih.gov/quickSearch/R01CA247517"}],"source":"grants"},"congress":{"count":1,"years":{"first":2018,"last":2018},"societies":["ASCO"],"shown":1,"withheld":0,"rows":[{"title":"Identifying chemotherapy-induced peripheral neuropathy (CIPN) and its treatment using claims data: A URCC NCORP and NIH Collaboratory study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2018,"role":"co_author","presentation_type":"unknown","contribution_type":"online_abstract","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e18707","source_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e18707","status":"verified"}],"source":"congress"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Anti-MAG Neuropathy","year":2026,"journal":"American Journal of Physical Medicine & Rehabilitation","source_url":"https://doi.org/10.1097/phm.0000000000002957","status":"verified"},{"title":"FOSTER: A Frequency-Ranked Text Entry Program to Improve Eye- Tracking Communication Efficiency in ALS","year":2026,"journal":"ScholarWorks -A service of University of Vermont Libraries (University of Vermont)","status":"verified"},{"title":"A Novel Text Input Program to Support Communication Efficiency in Amyotrophic Lateral Sclerosis: Protocol for a Pilot Feasibility Study (Preprint)","year":2026,"source_url":"https://doi.org/10.2196/preprints.107286","status":"verified"},{"title":"Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome","year":2025,"journal":"Brain","source_url":"https://doi.org/10.1093/brain/awaf102","status":"verified"},{"title":"Association of intraindividual variability in simple reaction time with balance and falls in older cancer survivors: A secondary analysis","year":2025,"journal":"Journal of Geriatric Oncology","source_url":"https://doi.org/10.1016/j.jgo.2025.102288","status":"verified"}],"most_cited":{"total":61,"shown":5,"withheld":56,"rows":[{"title":"Regional variation of Guillain-Barré syndrome","year":2018,"cited_by_count":333,"type":"article","source_url":"https://doi.org/10.1093/brain/awy232"},{"title":"The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling","year":2016,"cited_by_count":276,"type":"article","source_url":"https://doi.org/10.1001/jamaneurol.2016.0383"},{"title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","year":2021,"cited_by_count":231,"type":"article","source_url":"https://doi.org/10.1136/jitc-2021-002890"},{"title":"An International Perspective on Preceding Infections in Guillain-Barré Syndrome","year":2022,"cited_by_count":92,"type":"article","source_url":"https://doi.org/10.1212/wnl.0000000000200885"},{"title":"Current treatment practice of Guillain-Barré syndrome","year":2019,"cited_by_count":91,"type":"article","source_url":"https://doi.org/10.1212/wnl.0000000000007719"}]},"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/noah-kolb-md","status":"verified"}]},"mentions":{"total":7,"shown":3,"rows":[{"url":"https://podcasts.apple.com/us/podcast/january-7-2014/id266288159?i=1000426891665&uo=4","platform":"apple_podcasts","status":"provisional"},{"url":"https://podcasts.apple.com/us/podcast/october-2026-peripheral-nerve-and-motor-neuron/id1728724856?i=1000792365916&uo=4","platform":"apple_podcasts","status":"verified"},{"url":"https://continuumaudio.libsyn.com/october-2026-peripheral-nerve-and-motor-neuron-disorders-issue-with-dr-noah-kolb","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"M.D., University of Massachusetts Medical School","source_url":"https://www.uvm.edu/larnermed/bios/profile/noah-kolb","status":"verified","collected_at":"2026-11-03"},{"value":"American Board of Psychiatry & Neurology (Neurology)","source_url":"https://medicine.utah.edu/faculty/noah-kolb","status":"provisional","collected_at":"2026-11-03"}]},"roles":{"total":3,"shown":3,"rows":[{"value":"Board Member of The Toxic Neuropathy Consortium at the Peripheral Nerve Society","source_url":"https://uvmcommunity.uvm.edu/portal/uvmcc_members?cmd=memberbio&netid=nkolb","status":"verified","collected_at":"2026-11-03"},{"value":"Director of the Neurology Clerkship and Acting Internship (LCOM 3rd and 4th year students)","source_url":"https://www.uvm.edu/larnermed/bios/profile/noah-kolb","status":"verified","collected_at":"2026-11-03"},{"value":"Guest editor of the October Peripheral Nerve and Motor Neuron Disorders issue of Continuum","source_url":"https://www.facebook.com/continuumcme/posts/the-october-peripheral-nerve-and-motor-neuron-disorders-issue-guest-edited-by-dr/1811980967024214/","status":"provisional","collected_at":"2026-11-03"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Robert Larner College of Medicine Dean's Excellence in Research Award for a Mid-Career Investigator (2023)","source_url":"https://www.uvm.edu/larnermed/bios/profile/noah-kolb","status":"verified","collected_at":"2026-11-03"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"University of Utah (Assistant Professor of Neurology, past)","source_url":"https://orcid.org/0000-0003-2651-2349","status":"verified","collected_at":"2026-11-03"},{"value":"University of Utah, Neuromuscular Division of Neurology (Assistant Professor)","source_url":"https://medicine.utah.edu/faculty/noah-kolb","status":"provisional","collected_at":"2026-11-03"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Continuum Audio episode with Dr. Noah Kolb on the October 2026 peripheral nerve and motor neuron disorders issue","source_url":"https://continuumaudio.libsyn.com/october-2026-peripheral-nerve-and-motor-neuron-disorders-issue-with-dr-noah-kolb","status":"provisional","collected_at":"2026-11-03"},{"value":"Chemotherapy-Induced PN: What Patients Need to Know (webinar slides, Noah Kolb M.D)","source_url":"https://www.foundationforpn.org/wp-content/uploads/2026/09/CIPN-webinar_Kolb-slides-PDF.pdf","status":"provisional","collected_at":"2026-11-03"}]}},"similar":[{"name":"David Schneider","slug":"david-schneider","institution":"University of Vermont","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-schneider","json_url":"https://www.findmykol.com/kol/david-schneider/profile.json"},{"name":"Beth Kirkpatrick","slug":"beth-kirkpatrick","institution":"University of Vermont","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/beth-kirkpatrick","json_url":"https://www.findmykol.com/kol/beth-kirkpatrick/profile.json"},{"name":"Richard Page","slug":"richard-page","institution":"University of Vermont","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/richard-page","json_url":"https://www.findmykol.com/kol/richard-page/profile.json"},{"name":"Martin Lewinter","slug":"martin-lewinter","institution":"University of Vermont","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/martin-lewinter","json_url":"https://www.findmykol.com/kol/martin-lewinter/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-03"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-03"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2024","collected_at":"2026-11-03"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-03"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-03"}},"methodology_url":"https://www.findmykol.com/about#methodology"}